D-0647-2017 Class III Terminated
FDA drug recall D-0647-2017 was initiated by Fresenius Kabi USA, LLC on Mar 16, 2017 and is designated Class III. Reason for recall: Subpotent Drug The recall status is terminated (terminated Aug 28, 2018). Affected quantity: 118,224 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 12, 2017
- Initiation Date
- Mar 16, 2017
- Termination Date
- Aug 28, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 118,224 vials
Product description
Fluphenazine Decanoate Injection, USP; 25 mg/mL, 5mL vials, Rx only, APP Pharmaceuticals, LLC Schaumburg, IL 60173, NDC 63323-0272-05
Reason for recall
Subpotent Drug
Distribution pattern
Nationwide within the US
Code information
Lot #: 6111141, Exp. 07/17; 6111222, Exp. 08/17; 6112346, Exp. 01/18; 6112725, Exp. 03/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0647-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026